SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GMED
GMED 72.00+0.5%Dec 9 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: regine who wrote (45)12/3/1997 2:15:00 PM
From: Koerte Andreas  Read Replies (1) of 63
 
This week the termination of the cooperation between AGPH and Hoffmann La Roche concerning Head and Neck cancer was announced, which sent AGPH stock spiraling down. This could be interesting news to GMED, because the main partner of GMED is Boehringer Mannheim in Germany. Boehringer was swallowed by Hoffmann La Roche in June this year. The future of the HoffmannR. ties to GMED is open, what I heard from Boehringer. Maybe they even buy GMED, which is more likely now after the end of the AGPH aggreement. So hold on to your stocks!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext